Kintor starts a new Phase 3 for Pyri... (1+ year)

    Research/Science 7/19/2023
    The conversation discusses Kintor's initiation of a new Phase 3 trial to assess the long-term safety of Pyrilutamide (KX-826) for hair loss, which will last 52 weeks. Specific treatments mentioned include Pyrilutamide.
    View this post in the Community →

    Similar Community Posts Join

    6 / 727 results

    Related Research

    6 / 8 results